The ROE (Return on Equity) of Keros Therapeutics Inc (KROS) is -32.78%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -32.78% |
| 2023-12-31 | -46.05% |
| 2022-12-31 | -37.74% |
| 2021-12-31 | -24.15% |
| 2020-12-31 | -17.33% |
| 2019-12-31 | -2468.00% |
| 2018-12-31 | -10.47% |